The control of bleeding

Abstract

1. 1. The adrenochromazone complex was used clinically on seventy-seven patients whose condition was characterized by bleeding either secondary to a defect in the anatomic and/or physiologic integrity of the vasculature, as in hypertensive retinitis and hereditary familial telangiectasis, or in cases in which there was a traumatic interruption of vascular integrity following surgery and trauma. 2. 2. The drug is non-toxic for man in the doses reported. From our experience it appears that doses of less than 5 mg. either orally or parenterally are of dubious value.